Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)

Abroad (travel likely)Recruiting

Conditions

Waldenstrom Macroglobulinemia · Lymphoplasmacytic Lymphoma · Monoclonal B-Cell Lymphocytosis · Small Lymphocytic Lymphoma · CLL (Chronic Lymphocytic Leukemia)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • National Institutes of Health Clinical Center, Bethesda, Maryland, United States

    Contact: Study coordinator (Ingrid Frey) · ingrid.frey@nih.gov · 301-402-0797
Study leads
  • Adrian U Wiestner, M.D.

    Principal Investigator

    National Heart, Lung, and Blood Institute (NHLBI)